Цефалексин

Quick links to important sections

Цефалексин

Selected form

Medically reviewed

Marina Burgos

Last updated on 10/01/2026

This page provides general, reference-level information compiled from official medical sources. It is not a substitute for professional medical advice, diagnosis, or treatment. For decisions about your health, please consult a qualified healthcare professional.

Overview of Цефалексин

What is Cephalexin?

Property Description
Active ingredient Cephalexin Monohydrate
Form Capsules, Tablets, Oral Suspension (Granules/Powder)
Pharmacological class First-Generation Cephalosporin Antibiotic
Route of administration Oral (by mouth)
Origin Semisynthetic
Nature Bactericidal

Cephalexin: A Defining First-Generation Oral Antibiotic

Cephalexin is a semisynthetic beta-lactam antibiotic classified as a first-generation cephalosporin, used widely for its reliable efficacy against many common bacterial infections. This substance serves as the International Nonproprietary Name (INN), with the active ingredient typically present as Cephalexin Monohydrate. Unlike some later-generation cephalosporins, Cephalexin exhibits a strong activity profile against susceptible Gram-positive bacteria, often making it a preferred choice for treating infections such as cellulitis or certain respiratory tract issues. The drug is classified as a prescription-only (Rx) medicine due to its potent bactericidal properties.

Composition and Unique Oral Stability

The active ingredient provides acid-stability, a differentiating factor that makes the drug highly suitable for oral administration in various dosage forms, including capsules, tablets, and flavored oral suspension designed for use in pediatric patients. The drug's molecular structure (C16 H19 N3 O5 S) facilitates reliable absorption, leading to consistent bioavailability after ingestion. Popular brands with this formulation include Keflex and Keftab.

General Purpose: Targeted Bacterial Destruction

Cephalexin's general purpose is to achieve the swift and complete elimination of susceptible bacteria via its bactericidal action. The mechanism involves the drug's beta-lactam structure binding specifically to penicillin-binding proteins (PBPs), causing a failure in cell-wall synthesis. This process leads to the destruction of the bacterial cell, serving the primary therapeutic goal of resolving the source of the bacterial infection. This highly targeted, lethal action is the cornerstone of its clinical utility.

What side effects are possible with Цефалексин?

Possible Side Effects and Safety Information

Cephalexin, like all medications, can cause side effects. The majority of these are mild and often involve the gastrointestinal system.


Common Side Effects

Side effects that are generally considered common (occurring in ge1% of patients) often include:

  • Diarrhea: This is the most frequently reported side effect. Patients should maintain hydration.
  • Nausea and Vomiting: Taking the medication with food may help mitigate these symptoms.
  • Dyspepsia (indigestion) and Abdominal Pain.
  • Genital and Anal Pruritus (itching), Vaginitis, or Vaginal Discharge (which can be a sign of a yeast infection).

Serious Side Effects and Warnings

Though rare (occurring in <0.01% of patients or with unknown frequency), certain severe reactions require immediate medical attention:

  • Severe Allergic Reaction (Anaphylaxis): Signs include swelling of the face, lips, tongue, or throat; severe rash or hives; or difficulty breathing. Patients with a known penicillin allergy should inform their doctor, as a cross-reactivity may occur.
  • Severe Diarrhea: Watery, bloody, or prolonged diarrhea, even weeks after treatment, can be a sign of a serious condition called Clostridioides difficile-associated diarrhea (CDAD) or pseudomembranous colitis.
  • Liver or Kidney Problems: Symptoms may include unusual tiredness, dark urine, pale stools, or yellowing of the skin or eyes (jaundice).
  • Severe Skin Reactions: Including Stevens-Johnson syndrome or Toxic Epidermal Necrolysis, which may involve blistering, peeling skin, rash, and fever.

Contraindications and Precautions

Cephalexin is generally contraindicated in patients with a known allergy to cephalosporin antibiotics. Use with caution is advised for individuals with a history of kidney disease, liver disease, gastrointestinal conditions like colitis, or a history of seizures, as these conditions may increase the risk of side effects. Cephalexin may also interact with certain medications, such as metformin and probenecid, and may decrease the effectiveness of oral hormonal contraceptives.

Overdose and Emergency Response

Overdose and When to Seek Help

The information below is based strictly on the documented descriptions of overdose and mandated emergency actions found in official regulatory labeling and prescribing information.

Overdose Manifestations and Severity

An acute, massive overdose of Cephalexin may lead to a defined cluster of clinical signs. Documented manifestations primarily involve gastrointestinal distress, presenting as nausea, vomiting, epigastric distress, and diarrhea. More severe physiological outcomes officially reported include hematuria (blood in the urine), which reflects potential systemic distress. The risk of severe renal injury, such as acute tubular necrosis and toxic nephropathy, is officially associated with massive overdose. Neurological effects like convulsions are also recognized as possible severe manifestations. Furthermore, individuals with pre-existing renal dysfunction are noted in regulatory information as being at an increased risk for severe toxicity.

Required Emergency Actions and Management

Immediate medical attention must be sought if an overdose is suspected. Regulatory guidance mandates that individuals contact a Poison Control Center or emergency services immediately to initiate necessary protocols. The official management approach is defined as symptomatic and supportive treatment. The labeling explicitly states that no specific antidote is known for Cephalexin. Officially described supportive measures may include gastric lavage and the administration of activated charcoal. Close clinical observation and appropriate laboratory monitoring are required steps for managing the patient’s systemic effects in a hospital setting.

Therapeutic Uses of Цефалексин

Cephalexin is an oral antibiotic used for the management of various susceptible bacterial infections. By addressing the bacteria, it helps the body achieve therapeutic relief and can contribute to the overall process of recovery.

The medicine is typically used in clinical practice for: infections involving the respiratory tract, such as pharyngitis; middle ear infections (Otitis Media); skin and soft tissue infections (e.g., cellulitis); infections of bone tissue; and genitourinary tract infections (e.g., uncomplicated cystitis). The use is focused on bacterial strains considered susceptible to Cephalexin.

Cephalexin is used to treat certain infections caused by bacteria such as pneumonia and other respiratory tract infections; and infections of the bone, skin, ears, genital, and urinary tract.


Quick Fact: May help manage symptoms such as fever and pain that are associated with the underlying infection

Regulatory References

  1. NIH MedlinePlus guidance

Eligibility and Restrictions for Use

Eligibility Map: Who Can and Cannot Use Cephalexin — Official Regulatory Information


Eligibility Scope

Category Regulatory Status (Official Statement)
Populations for whom use is allowed Adults and Pediatric Patients are eligible for use under established labeled conditions.
Populations for whom use is not recommended Caution is required for patients with a history of colitis or gastrointestinal disease due to the risk of C. difficile-associated diarrhea (CDAD).
Populations for whom use is contraindicated Patients with known hypersensitivity to cephalexin or other members of the cephalosporin class of antibacterial drugs.
Age-related eligibility rules Pediatric Patients (over 1 year of age) are eligible. Older Adults are eligible, but caution is advised due to the higher incidence of decreased renal function.
Condition-specific eligibility rules Impaired Renal Function (e.g., creatinine clearance less than 30 mL/min): Use is restricted and requires careful monitoring due to the risk of drug accumulation and potential neurotoxicity.
Pregnancy and lactation eligibility status Pregnancy: Use is generally permitted when clinically needed; available data has not established drug-associated risks of adverse developmental outcomes. Lactation: Use is permitted but advised with caution, as the drug is excreted in human milk.

Resulting Eligibility Structure

Official eligibility statements:

  • The medicine is contraindicated in any individual with a known allergy to cephalexin or any other cephalosporin drug.
  • Patients with markedly impaired renal function are eligible only under conditional use, requiring careful observation.
  • A history of penicillin allergy or colitis imposes a regulatory restriction requiring heightened caution before use.

Connection to the overall eligibility profile: Official regulatory documents define who can and cannot use Cephalexin primarily through absolute contraindication based on known severe allergies and conditional use/restriction based on physiological status, such as compromised kidney function or a relevant comorbidity like colitis. These rules explicitly limit the eligible population and mandate caution for groups where drug elimination is compromised.

What should I know about interactions with other medicines?

Interactions with other medicines and products

Cephalexin interaction patterns are officially documented to involve pharmacokinetic modifications (altered drug concentrations) and pharmacodynamic enhancement (additive effects).

Documented Drug-Drug and Drug-Substance Interactions

Interacting Substance/Class Official Regulatory Description of Interaction
Probenecid (Anti-gout medicine) Inhibits the renal tubular secretion of Cephalexin, leading to increased and prolonged plasma concentrations and systemic exposure of Cephalexin.
Metformin (Anti-diabetic medicine) Cephalexin inhibits the active renal tubular secretion of Metformin, resulting in increased peak plasma concentration (Cmax) and Area Under the Curve (AUC) of Metformin.
Warfarin and other Oral Anticoagulants May be associated with reduced prothrombin activity and/or a prolonged Prothrombin Time (INR), which can potentiate the anticoagulant effect.
Zinc-Containing Products (Supplements) May interfere with the gastrointestinal absorption of Cephalexin, resulting in reduced systemic exposure.

Timing and Laboratory Constraints

To avoid a significant reduction in Cephalexin absorption, Zinc-containing products are required to be administered at least 3 hours after the Cephalexin dose. Administration of Cephalexin may also result in a false-positive reaction for glucose in the urine when tested with reducing substance methods, and positive Direct Coombs' tests have been reported during treatment with cephalosporin antibacterial drugs.

Mechanism of Action

Targeting Bacterial Cell Wall Formation

Цефалексин acts as a specific irreversible inhibitor of bacterial Penicillin-Binding Proteins (PBPs), which are essential enzymes for the cross-linking of the peptidoglycan cell wall. This molecular interaction stops the structural synthesis of the cell, initiating the mechanistic consequence of bacterial cell lysis (rupture and death).


Modulating Pathogen Survival

The primary mechanistic outcome of Цефалексин's action is the modulation of the fundamental process of bacterial survival and proliferation. By triggering the collapse of the cell wall, the compound initiates a bactericidal cascade that reduces the viable bacterial population. This mechanism contributes to the compound's overall profile as a bactericidal agent.


Constraints on Mechanistic Activity

The execution of this mechanism is intrinsically constrained by bacterial defense systems, particularly the presence of beta-lactamase enzymes or modified PBPs. These elements interfere with the drug's core chemical structure or target binding, resulting in the inactivation of the drug or reduced PBP affinity, which constrains the beta-lactam mechanism.

Dosage and Administration Information

How to Use Cephalexin

Cephalexin administration is organized to ensure appropriate dosing and scheduling. The medicine is classified for oral use only, available in several forms including capsules, tablets, and a powder for oral suspension.


Dosing and Frequency Patterns

The total adult daily dose typically ranges from 1 gram to 4 grams, which is administered in equally divided doses. Common regimens involve taking the medicine every 6 hours or every 12 hours, such as 250 mg four times daily or 500 mg twice daily. This divided schedule is used for maintaining adequate systemic concentrations.

Treatment duration generally spans 7 to 14 days, with a duration of at least 10 days for infections caused by beta-hemolytic streptococci.


Administration Conditions and Adjustments

Cephalexin is acid-stable and may be administered without regard to meals. For the oral suspension form, the powder is reconstituted prior to use by adding the specified volume of water, and the liquid is shaken well before each dose is measured.

Specific dosing adjustments are utilized for certain populations. For pediatric patients (over one year of age), the dose is calculated based on body weight (typically 25 to 50 mg/kg/day) in equally divided doses. Furthermore, dosage is adjusted for adult and pediatric patients with impaired renal function based on their measured Creatinine Clearance (CrCl).

Recent Clinical Evidence

Research Evidence / Overview of Studies for Цефалексин

This document provides an overview of the research conducted on Cephalexin, detailing the types of studies performed, the nature of the observations made, and the areas where information is still limited or uncertain. This summary is strictly descriptive and does not offer clinical advice, dosing information, or recommendations for use.


Evidence for Use in Skin and Soft Tissue Infections

Cephalexin was studied for use in uncomplicated cellulitis and impetigo, utilizing Randomized Controlled Trials (RCTs) across adults and pediatric populations. Research examined outcomes related to physical discomfort, monitoring for clinical success and treatment failure. Findings describe patterns observed in the studies related to clinical resolution in susceptible infections. However, evidence is limited regarding whether a higher dose regimen can provide better outcomes than a standard dose, and results apply only to the populations studied that exclude specific resistant bacterial strains like MRSA.


Evidence for Use in Urinary Tract Infections

Research has explored whether the agent has an impact in uncomplicated cystitis, relying on historical regulatory trials and Retrospective Comparative Cohort Studies. Studies monitored clinical and microbiological clearance. Despite foundational data, comparative evidence is lacking against many newer antibiotic options now often prioritized for these infections. The certainty remains low regarding the optimal dosing frequency—meaning the question of which schedule has been most observed is still uncertain in the research literature.


Evidence for Use in Respiratory Tract Infections and Otitis Media

The agent was evaluated in conditions such as streptococcal pharyngitis and otitis media. The pivotal evidence is historical, meaning it was often conducted before contemporary trial standards were established. Studies explored the resolution of acute symptoms and bacterial clearance. Evidence quality varies across studies, and subgroup findings are uncertain concerning its effect against certain non-streptococcal bacteria.


Evidence Gaps and Follow-up Limitations

For all indications, long-term effects are not fully established, as follow-up durations were limited in most clinical trials. Furthermore, data for certain groups remain insufficient, particularly concerning large-scale, dedicated trials focusing on patients with multiple comorbid conditions. Comparative evidence is lacking across the board, which means research provides context but not individual predictions, highlighting areas where more research is ongoing.

Key Studies & References

  1. Cephalexin (NBK549780) - General Pharmacology and Clinical Use Overview (NIH/NCBI)

Frequently Asked Questions (FAQ)

Common questions about Цефалексин (FAQ)

Q: What infections is Cephalexin most often prescribed for?

A: Official product information indicates that Cephalexin may be used for treating infections caused by susceptible bacteria in several body areas. These indications typically cover infections of the respiratory tract, middle ear, skin and soft tissues, bones, and the urinary tract. The decision regarding the appropriate infection to treat is made by a qualified healthcare provider.

Q: What is the difference between Cephalexin and other cephalosporins?

A: Cephalexin is classified as a first-generation cephalosporin antibiotic. This classification means it primarily shows strong activity against susceptible Gram-positive bacteria, which are commonly associated with skin and soft tissue issues. Later generations of cephalosporins generally have an expanded or different spectrum of activity, particularly against various Gram-negative organisms.

Q: Why does a rash sometimes appear after taking Cephalexin?

A: A rash, hives, or itching may be a manifestation of an allergic reaction to antibiotics like Cephalexin. Official product information indicates that these reactions can range from mild to severe. Any appearance of a new rash should be reported to a healthcare professional.

Q: What should be done if a severe allergic reaction to Cephalexin occurs?

A: Official medical guidance emphasizes that symptoms of a severe allergic reaction—such as difficulty breathing, swelling of the face, tongue, or throat, or fainting—require immediate medical attention. If these serious symptoms occur, seeking emergency medical care immediately is advised.

Q: Why is Cephalexin sold in different forms (capsules, suspension)?

A: Cephalexin is supplied in multiple forms, including capsules, tablets, and oral suspension. According to regulatory documents, providing various forms is done for ease of use. The oral suspension, for instance, is designed specifically for pediatric patients or individuals who may have difficulty swallowing pills.

Q: Is Cephalexin considered a broad-spectrum or narrow-spectrum antibiotic?

A: Cephalexin is classified as a first-generation broad-spectrum antibiotic. This designation means it is active against a wide range of bacteria, including many Gram-positive and some Gram-negative microorganisms, making it suitable for treating various common bacterial infections.

Q: Are there studies confirming Cephalexin's effectiveness against Staphylococcus aureus?

A: Yes, official labeling indicates that Cephalexin may be prescribed for the treatment of skin and skin structure infections caused by susceptible strains of bacteria, including Staphylococcus aureus and Streptococcus pyogenes.

Q: What is resistance to Cephalexin?

A: Resistance occurs when bacteria develop the ability to withstand the effects of the antibiotic. This involves mechanisms where bacteria can produce enzymes (like beta-lactamase) that break down the drug's structure, or they modify the drug's intended targets.

Q: What is the FDA classification of Cephalexin for use in pregnancy?

A: Based on the old FDA classification system, Cephalexin was categorized as Pregnancy Category B. This status indicated that studies in pregnant animals had not shown harm to the fetus. However, controlled studies in pregnant women are not available, and use is determined by a healthcare provider when clinically necessary.

Q: Does Cephalexin affect gut microflora?

A: Yes, like most antibiotics, Cephalexin may disrupt the natural balance of gut microflora. Official information notes that this imbalance is the cause of the most common side effect, which is diarrhea. In rare circumstances, this can lead to a more severe condition called C. difficile-associated diarrhea.

Q: What formulation strengths is Cephalexin usually available in for adults?

A: Official drug labels indicate that Cephalexin is typically supplied in capsule and tablet strengths of 250 mg and 500 mg for adults. It is also available as an oral suspension in concentrations such as 125 mg/5 ml and 250 mg/5 ml.

Q: How does Cephalexin in suspension form differ from capsules?

A: Capsules are taken whole and stored at controlled room temperature. The oral suspension is supplied as a powder that requires mixing with water (reconstitution). The resulting liquid is intended for refrigerated storage and has a limited shelf life, typically 14 days, before it must be discarded.

Q: How quickly does Cephalexin start working?

A: According to clinical pharmacology data, the concentration of Cephalexin in the blood reaches its peak concentration approximately 1 hour after being taken. While the drug starts working immediately, official sources note that noticeable improvement in infection symptoms may take up to 48 hours of treatment.

Q: What happens if a dose of Cephalexin is missed?

A: Official instructions advise that if a dose is missed, it can typically be taken as soon as it is remembered. However, patients are cautioned that they should not take a double dose to compensate for the one they missed.

Q: Why is it important to take Cephalexin until the end of the prescribed course?

A: Completing the entire prescribed course is highly recommended to minimize the risk of developing drug-resistant bacteria. Adherence is considered important to ensure the elimination of the susceptible pathogen.

Q: Is fatigue considered a common side effect of Cephalexin?

A: Yes, official sources list excessive tiredness or weakness among the possible side effects associated with Cephalexin. If a patient experiences unusual fatigue, they should note that this is a recognized adverse reaction.

Q: Can alcohol be consumed during Cephalexin treatment?

A: Official reports generally do not document a direct or dangerous pharmacological interaction between Cephalexin and alcohol. However, consuming alcohol may worsen common side effects of the antibiotic, such as dizziness, nausea, and drowsiness.

Q: Is there an interaction between Cephalexin and pain relievers?

A: Official interaction checkers typically show no significant interaction with common over-the-counter pain relievers like acetaminophen. However, official regulatory information advises caution when used concurrently with Nonsteroidal Anti-inflammatory Drugs (NSAIDs) due to potential additive effects or increased risk of side effects.

Q: Can Cephalexin cause headaches?

A: Yes, official regulatory information specifically lists headache as one of the possible side effects of Cephalexin. If headaches persist or are severe, this is a symptom that may warrant consultation with a healthcare provider.

Q: Can Cephalexin cause sleep problems?

A: Official sources do not directly list sleep problems, but they do list central nervous system (CNS) effects that could indirectly affect sleep. These effects include the possibility of confusion and agitation (excitement) as recognized adverse reactions.

Q: How long does Cephalexin stay in the body after the last dose?

A: According to clinical pharmacokinetics data, Cephalexin has a relatively short presence in the body. For adults with normal kidney function, the drug's half-life is typically between 0.5 and 1.2 hours, with the majority of the drug eliminated from the body within 8 hours.

Q: Does Cephalexin affect the ability to drive?

A: Official product information notes that because Cephalexin may cause side effects like dizziness or excessive tiredness, caution should be exercised before operating machinery or driving.

Q: Can Cephalexin change the color of urine?

A: Official reports indicate that changes in urine color (such as pink, red, or dark brown) have been reported, primarily in cases where high drug concentrations were present.

Q: Is Cephalexin's effectiveness for infection prevention proven?

A: Official regulatory instructions indicate that the medication is indicated for the treatment or prophylaxis (prevention) of infections caused by susceptible bacteria. This means prevention is a recognized and labeled use.

How should Цефалексин be stored and disposed of?

How to Store and Dispose of Цефалексин?

Storage Requirements

Product Form Storage Temperature Stability/Handling
Capsules and Tablets Controlled Room Temperature (20 C to 25 C) Keep in original, tight container.
Dry Powder for Suspension Controlled Room Temperature (20 C to 25 C) Keep in original, tight container.
Reconstituted Suspension Refrigerated (2 C to 8 C) Discard unused portion after 14 days. Shake well before use. Protect from freezing.

Disposal and Safety

Always store Цефалексин and all medications out of reach of children. Unused or expired medication should be disposed of properly. Do not flush Цефалексин down a toilet or pour it down a drain unless a drug-take back program is unavailable and the label instructs otherwise. Follow local guidelines for drug disposal, or mix the medication with an undesirable substance, seal it in a bag, and place it in the household trash.

Attention! Always consult to a doctor or pharmacist before using pills or medicines.

Available in countries:

Equivalent of Цефалексин found in:

A-Z Index: